2009
DOI: 10.1007/s00441-009-0768-z
|View full text |Cite
|
Sign up to set email alerts
|

Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12

Abstract: In situ tissue engineering is a promising approach in regenerative medicine, with the possibility that adult stem or progenitor cells will be guided chemotactically to a tissue defect and subsequently differentiate into the surrounding tissue type. Mesenchymal stem cells (MSC) represent attractive candidate cells. Chemokines such as CXCL12 (SDF-1alpha) chemoattract MSC, but little is known about the molecular processes involved in the chemotaxis and migration of MSC. In this study, MSC recruitment by CXCL12 wa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
37
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(37 citation statements)
references
References 56 publications
0
37
0
Order By: Relevance
“…[25,26]). Expression of Nur77 has not been described in MSC before, whereas increased expression of Nurr1 was observed in adult BMSC exposed to SDF-1a [44] or CXCL7 [45]. In these 2 studies, no functional experiments on Nurr1 were performed.…”
Section: Overexpression Of Nur77 or Nurr1 Does Not Affect Immune Suppmentioning
confidence: 99%
“…[25,26]). Expression of Nur77 has not been described in MSC before, whereas increased expression of Nurr1 was observed in adult BMSC exposed to SDF-1a [44] or CXCL7 [45]. In these 2 studies, no functional experiments on Nurr1 were performed.…”
Section: Overexpression Of Nur77 or Nurr1 Does Not Affect Immune Suppmentioning
confidence: 99%
“…Enhanced recruitment of autologous stem cells may improve tissue responsiveness and jumpstart stem cell participation in healing (Thevenot et al 2010). Taken together with what is already known about MSC recruitment and differentiation, these results suggest that guiding MSCs to sites of damaged tissue is a promising approach for in situ regenerative medicine (Stich et al 2009). Our observations support the notion that SDF-1a is a promising candidate for in situ recruitment in regenerative therapies.…”
Section: Discussionmentioning
confidence: 89%
“…The cells will subsequently differentiate into the surrounding tissue type and affect repair at the injury site. 18 Poor homing ability of the stem cells to bone could result in a significant reduction in bone formation which ultimately contributes to osteoporosis. 19 …”
Section: Discussionmentioning
confidence: 99%